Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Cambridge Heartwear is a medical technology company that develops AI-driven wearable devices for real-time heart monitoring and stroke prevention. Spun out of the University of Cambridge, the company's flagship product, HeartSense, is a medical-grade, multi-channel ECG wearable that uses proprietary artificial intelligence to detect heart rhythm disorders like atrial fibrillation. The technology integrates advanced machine learning with clinical-grade hardware to provide continuous, real-time diagnostics without the need for a prescription. By automating the interpretation of complex ECG data, Cambridge Heartwear aims to identify cardiac irregularities early and reduce the global burden of stroke and heart disease.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Cambridge Heartwear.